Journal of Food BiochemistryCancer BiologyPeer-reviewed journal article
Garcinone C suppressed the proliferation of gastric cancer cells through regulating Hedgehog signaling
Yimeng ZhouiD, Jin Tae KimiD, Jung Won Kwon, Ga-Yeon LeeiD, Hui Mang Son, Kang Hyuk Lee, Shuai Qiu, Hong Jin LeeiD
Abstract
Garcinone C, a xanthone derived from Garcinia mangostana L, possesses antioxidant and anti-cancer effects. However, its role in gastric cancer remains unexplored. This study aimed to investigate the effects of garcinone C on gastric cancer cell proliferation and its underlying mechanism. We found that garcinone C suppressed gastric cancer cell growth by inducing G0/G1 arrest and apoptosis in a dose-dependent manner. Furthermore, garcinone C downregulated G0/G1 phase markers Cyclin D1 and p21, as well as apoptosis markers Bax, Bcl-2, cleaved-PARP, and c-caspase 3. Following the previous evidence demonstrated that aberrant Hedgehog (Hh) signaling is implicated in gastric cancer development, we confirmed that inhibiting Gli1/2 reduced the growth of AGS and MKN74 cells. Furthermore, garcinone C exerted similar effects to Gant61, inhibiting Hh signaling by reducing Gli1/2 levels and blocking their nuclear translocation. These findings suggest that garcinone C inhibits gastric cancer proliferation via the Hh signaling, indicating its potential as a therapeutic agent for treating gastric cancer.
- organism: human
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 1
- FWCI
- 0.54
- Field percentile
- top 29%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- INHBA promotes the progression of gastric cancer by activating MAPK signaling pathway via targeting ITGA6
Guojian Zhou, Rui Zhang, … Jia Wang·Oncology Research Featuring Preclinical and Clinical Cancer TherapeuticsPeer-reviewed·Jan 1, 2026
- Tegaserod maleate suppresses the growth of gastric cancer in vivo and in vitro by targeting MEK1/2
K. Liu, y. jiang, … y. chen·CancersPeer-reviewed·Jul 23, 2022
- Umbelliprenin isolated from Ferula sinkiangensis inhibits tumor growth and migration through the disturbance of Wnt signaling pathway in gastric cancer
Lijing Zhang, Xiaobo Sun, … Li Cao·PLoS ONEPeer-reviewed·Jul 1, 2019
- Nociceptive neurons interact directly with gastric cancer cells via a CGRP/Ramp1 axis to promote tumor progression
X. Zhi, F. Wu, … T. C. WANG·bioRxiv·Mar 4, 2024
- Site-specific cholesterol depletion therapy for gastric cancer
Simona Kavrakova, AC Sharma, … Wonhwa Cho·Journal of Lipid ResearchPeer-reviewed·Aug 18, 2026
- YTHDF3 promotes the progression of gastric cancer by activating the Wnt/β-catenin signaling pathway by targeting NEK7
Xiaoran Sun, Yifan Chen, … Weifang Yu·Journal of Gastroenterology and HepatologyPeer-reviewed·Jul 30, 2026